Insider · CIK 0001638945
Dirk Thye
Files at QNCX (Quince Therapeutics, Inc.). First filing -, latest -.
Dirk Thye files SEC Form 4 as CEO and director at QNCX (Quince Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dirk Thye has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | QNCX Quince Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +1,000,000 | $0.00 | $0 | 1,000,000 | Jan 23, 2026 |
| Dec 10, 2025 | QNCX Quince Therapeutics, Inc. | GGift Common Shares | -739,885 | $0.00 | $0 | 255,000 | Dec 12, 2025 |
| Dec 10, 2025 | QNCX Quince Therapeutics, Inc. | GGift Common Sharesindirect: Thye Trust | +739,885 | $0.00 | $0 | 739,885 | Dec 12, 2025 |
| Jun 18, 2025 | QNCX Quince Therapeutics, Inc. | AGrant or award Common Shares | +150,944 | $1.20 | $181k | 994,885 | Jun 23, 2025 |
| Jun 18, 2025 | QNCX Quince Therapeutics, Inc. | AGrant or award Warrantsderivative | +150,944 | $0.13 | $19k | 150,944 | Jun 23, 2025 |
Questions about Dirk Thye
Answered from the filings on this page, as of the latest one.
Is Dirk Thye buying or selling?
Dirk Thye has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dirk Thye's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dirk Thye has 0.
Where does Dirk Thye file Form 4?
Dirk Thye has filed Form 4 at QNCX (Quince Therapeutics, Inc.) as CEO and CMO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.